NACI advice to mix vaccines gets varied reaction from AstraZeneca double-dosers

On June 1, NACI had said AstraZeneca recipients 'could' get Pfizer-BioNTech or Moderna for their second shot if they wanted, but on Thursday it went further to say an mRNA vaccine was the 'preferred' choice.